Author

Srinivasa P. S. Rao

Novartis (United States)ORCID 0000-0002-7156-5725Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:host-pathogen & immune response· 2 Organism:mouse· 2 Research Focus:cell type annotation· 1 Research Focus:cell-cell communication· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Organism:human· 1

Frequent Co-Authors

Adriana GruppiiD· 1 shared Alexander Theodore Chao· 1 shared Amanda Fortes FranciscoiD· 1 shared Anke Harupa-ChungiD· 1 shared Armand Guiguemde· 1 shared Calla Martyn· 1 shared Camila M. S. Giménez· 1 shared Carolina Abrate· 1 shared

Activity by Year

2025-2025 · peak 3/yr

Co-Author Collaboration Network

10 top collaborators · 13 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

Adriana GruppiORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

MicrobiologybioRxivPreprintOct 26, 2025

Screening of a chemogenetic library unveils dual-stage antimalarials with low cytotoxicity

Laura Torres, Matthew E. Fishbaugher, Melanie Lam…·Gabriel Mitchell

This study screens a chemogenetic library to identify antimalarial compounds with dual-stage activity against Plasmodium liver and blood stages, showing low cytotoxicity.

DOI 10.1101/2025.10.26.684713

humanexperimental assay

𝕏 PostBluesky

MicrobiologyAntimicrobial Agents and ChemotherapyPeer-reviewedApr 14, 2025

Statins do not reduce the parasite burden during experimental Trypanosoma cruzi infection

Sarah Razzaq, Francisco Olmo, Suresh B. Lakshminarayana…·Amanda Fortes Francisco

This study shows statins do not reduce parasite burden in a mouse model of Trypanosoma cruzi infection, suggesting clinical trials for trypanocidal activity are unjustified.

DOI 10.1128/aac.00135-25

mouseexperimental assay

𝕏 PostBluesky

ImmunologyPLoS PathogensPeer-reviewedJan 30, 2025

Tissue damage during acute Trypanosoma cruzi infection is associated with reduced reparative regulatory T cell response and can be attenuated by early interleukin-33 administration.

Santiago Boccardo, Constanza Rodríguez, Camila M. S. Giménez…·Eva V. Acosta Rodríguez

This study shows that reduced trTregs during T. cruzi infection correlates with tissue damage, and early IL-33 treatment increases trTregs and reduces damage.

12 citationstop 2%

mouseexperimental assay

𝕏 PostBluesky